Bamco Inc. NY Has $232.05 Million Holdings in Houlihan Lokey, Inc. $HLI

Bamco Inc. NY cut its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 1.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,130,190 shares of the financial services provider’s stock after selling 15,953 shares during the period. Bamco Inc. NY owned about 1.61% of Houlihan Lokey worth $232,051,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of HLI. Royal Bank of Canada raised its position in Houlihan Lokey by 14.4% in the 1st quarter. Royal Bank of Canada now owns 49,584 shares of the financial services provider’s stock valued at $8,008,000 after purchasing an additional 6,253 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Houlihan Lokey by 50.0% during the first quarter. AQR Capital Management LLC now owns 29,654 shares of the financial services provider’s stock worth $4,598,000 after purchasing an additional 9,891 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Houlihan Lokey in the first quarter valued at $18,964,000. Goldman Sachs Group Inc. increased its stake in shares of Houlihan Lokey by 5.7% in the first quarter. Goldman Sachs Group Inc. now owns 415,743 shares of the financial services provider’s stock valued at $67,143,000 after buying an additional 22,553 shares in the last quarter. Finally, ProShare Advisors LLC raised its holdings in shares of Houlihan Lokey by 3.7% in the second quarter. ProShare Advisors LLC now owns 2,385 shares of the financial services provider’s stock valued at $429,000 after buying an additional 84 shares during the last quarter. Institutional investors own 78.07% of the company’s stock.

Houlihan Lokey Stock Down 0.2%

Shares of HLI stock opened at $139.57 on Friday. The firm has a market cap of $9.74 billion, a price-to-earnings ratio of 21.44 and a beta of 0.95. Houlihan Lokey, Inc. has a 12 month low of $137.99 and a 12 month high of $211.78. The stock has a 50-day moving average price of $170.57 and a 200 day moving average price of $182.15.

Houlihan Lokey (NYSE:HLI) last released its earnings results on Thursday, January 29th. The financial services provider reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Houlihan Lokey had a net margin of 16.91% and a return on equity of 24.46%. The company’s quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.64 EPS. Sell-side analysts predict that Houlihan Lokey, Inc. will post 5.98 earnings per share for the current fiscal year.

Houlihan Lokey Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, March 15th. Investors of record on Monday, March 2nd will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, March 2nd. Houlihan Lokey’s payout ratio is 36.87%.

Insider Activity at Houlihan Lokey

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 500 shares of Houlihan Lokey stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $174.17, for a total transaction of $87,085.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert A. Schriesheim sold 5,000 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $170.86, for a total transaction of $854,300.00. Following the sale, the director owned 27,982 shares of the company’s stock, valued at $4,781,004.52. The trade was a 15.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 22.83% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. BMO Capital Markets upped their price target on shares of Houlihan Lokey from $209.00 to $211.00 and gave the stock an “outperform” rating in a research report on Thursday, January 29th. Weiss Ratings downgraded shares of Houlihan Lokey from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, March 9th. Keefe, Bruyette & Woods reduced their target price on shares of Houlihan Lokey from $218.00 to $214.00 and set an “outperform” rating on the stock in a research report on Thursday, January 29th. UBS Group decreased their price target on shares of Houlihan Lokey from $196.00 to $163.00 and set a “neutral” rating on the stock in a research note on Thursday. Finally, The Goldman Sachs Group lowered their price target on shares of Houlihan Lokey from $243.00 to $210.00 and set a “buy” rating for the company in a report on Thursday. Five equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $204.57.

About Houlihan Lokey

Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.

The firm’s core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.